Boston · Hybrid · $120k–$150k/yr
Frontier Medicines
Work at Frontier Medicines?
About Frontier Medicines
Frontier Medicines is a precision medicine company with offices in South San Francisco, California and Boston, Massachusetts. It has pioneered a discovery and development platform designed to generate medicines against disease-causing proteins previously considered undruggable. Frontier Medicines deploys chemoproteomics, covalent drug discovery, and machine learning in its work. Its lead program targets both the activated and inactive forms of KRAS G12C, a driver in cancers that was previously undruggable. The company's pipeline reflects a mission to advance science to defeat disease, starting with cancer, and it operates in the field of precision medicine with a focus on cancer.
Open positions · 3
Boston · Hybrid · $185k–$250k/yr
South San Francisco · On-site · $100k–$159k/yr
Company at a glance
Location
Life at Frontier Medicines
Frequently asked questions
Companies similar to Frontier Medicines
EVANIUM is a Regensburg, Germany–based life-science startup that aims to unleash the potential of plant compounds. The company uses its OPTISOLV platform to transform plant extracts into highly water-soluble, stable ingredients, serving customers in Germany and the USA and drawing international interest from Korea and beyond. With a 12-person team, EVANIUM has raised 2.2 million euros in seed funding led by Foodlabs and Phis, with investors including Böhringer Ingelheim and Razorfarm, and has earned an award at Vitafood. This year the company reported 350,000 euros in revenue and produced 2.5 tons of raw material, positioning itself as an innovative player in the plant-based ingredient market.
Arbio, headquartered in Berlin, Germany, is building an AI-native property management platform for short-term rentals across Europe. It currently manages over 1,000 apartments and operates real properties in Berlin, Hamburg, Vienna, and Leipzig, with plans to expand to additional European cities. The company has raised a $36 million Series A funding and maintains an engineering team of five engineers. Arbio’s platform uses AI to observe, decide, and act on real-world property operations with humans in the loop, enabling AI-assisted management of short-term rental properties across Europe.
Duna is an AI-native business identity platform focused on KYB, KYC, AML, and lifecycle compliance, enabling enterprises to manage risk and regulatory adherence across the customer journey. By delivering automated identity verification, ongoing monitoring, and risk scoring, Duna helps organizations streamline compliance while reducing friction for legitimate customers. Global customers like Plaid, Moss, and Bol rely on Duna to maintain robust, scalable identity programs.



